FRMD6-AS1
Putative uncharacterized protein FRMD6-AS1
Also known as: FMAS1_HUMAN
Protein identityUniProt · HPA
OverviewNCBI Gene
No narrative summary is available for FRMD6-AS1 in this catalog release; identity and structured annotations are shown without generated factual claims.
Canonical amino-acid sequenceUniProt
363 residues, UniProt reviewed canonical sequence.
>P0C7T7|FRMD6-AS1
1 MQLGRSGRRS QKQKHEVDEV YFTLTRVDRS CPYLTVPGPP GAESGAPVRL GLRQRAVSSS
61 RNPNSAGRTP NSYLTQAPVW RRSAPAQPPA PQTRHFPGRG ADPALGSLPA AGLSGLCART
121 TGGTAQPPGA RDSGASPGAQ PQRHRPGCRG PPGSPVIRGP PRCREPGTAH GAQTPPPTRP
181 NWPRRQPSRG SCALSSRQYG ERPPAPPWTQ PSVPRRGAAT WGQEKAEYAT PLGTQEARRA
241 SGGRGGVDHG DQGLSPCCGD GGARGRRRLP TFWPSGLLRL RLDSLGALPP EPSRAGRGRL
301 FGLSVVLLKR NAGGEATPRE GGPRRRWLRE SCSPLPARHS RRRASWVSRW MEGAPPRMPS
361 LPLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FRMD6-AS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.74
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FRMD6-AS1 as an antibody target. Whether an autoantibody or antibody against FRMD6-AS1 could matter depends on whether native FRMD6-AS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FRMD6-AS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FRMD6-AS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...